Summary of Study ST000867

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000381. The data can be accessed directly via it's Project DOI: 10.21228/M8SW34 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files
Study IDST000867
Study TitleMetabolic Profiling of Date Palm Fruits (part II)
Study SummaryIn this study, two independent large cohorts of mature dates exhibiting substantial diversity in origin, varieties and fruit processing conditions were measured by metabolomics techniques in order to identify major determinants of the fruit metabotype. Additional samples reflecting different stages of date fruit ripening process has been included for 10 different fruit varieties. This study includes updated date photographs and combined results data (GCMS/LCMS) and technical validation data, see downloadable files section to access this information.
Institute
Weill Cornell Medicine, Qatar
DepartmentBioinformatics Core
LaboratorySuhre Lab
Last NameSuhre
First NameKarsten
AddressEducation City
Emailnis2034@qatar-med.cornell.edu
Phone+97433888408
Submit Date2017-08-02
Analysis Type DetailGC-MS/LC-MS
Release Date2017-10-03
Release Version1
Karsten Suhre Karsten Suhre
https://dx.doi.org/10.21228/M8SW34
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Treatment:

Treatment ID:TR000908
Treatment Summary:The aim of this study was to determine metabolic phenotype of the date palm fruits without any treatment at the baseline.
  logo